Cardiac
According to the haemostatic agent’s review1 article, an ideal haemostatic agent would achieve haemostasis and show other potential benefits including:
“better visualization of the surgical area, shorter operative times, decreased requirement for transfusions, better management of an anticoagulated patient, decreased wound healing time and overall improvement in patient recovery time”.
Based on self-assembling peptide technology, 3-D Matrix has obtained CE mark approval for the surgical haemostatic agent, PuraBond, which has multiple unique features that distinguish it from competitors and make it highly suitable for cardiac surgery.
PuraBond is suitable for a variety of situations.
PuraBond is suitable for a variety of situations.
PuraBond is suitable for a variety of situations.
Read our case reports
Join us with the international experts:
Please read carefully the instructions for use, indications and contraindications of the product.3
1. Comparison of hemostatic agents used in vascular surgery; Krishna S. Vyas, Sibu P. Saha; Expert Opin Biol Ther. 2013 December; 13(12): 1663–1672.
2. PuraBond IFU-009 Rev 2
Medical Specialities